Print Page

Medical Cannabis Significantly Safer than Opioids for Seniors with Chronic Pain

Published: 2018-02-13
Author: American Associates, Ben-Gurion University of the Negev - Contact: aabgu.org
Peer-Reviewed: N/A
Related Papers: Latest Items - Full List

On This Page: Summary - Main Article - About/Author

Synopsis: Research shows medical cannabis therapy can significantly reduce chronic pain in patients age 65 and older without adverse effects.

Medical cannabis therapy can significantly reduce chronic pain in patients age 65 and older without adverse effects, according to researchers at Ben-Gurion University of the Negev (BGU) and the Cannabis Clinical Research Institute at Soroka University Medical Center.

Main Digest

Medical cannabis therapy can significantly reduce chronic pain in patients age 65 and older without adverse effects, according to researchers at Ben-Gurion University of the Negev (BGU) and the Cannabis Clinical Research Institute at Soroka University Medical Center.

advertisement

The new study, published in The European Journal of Internal Medicine, found cannabis therapy is safe and efficacious for elderly patients who are seeking to address cancer symptoms, Parkinson's disease, post-traumatic stress disorder, ulcerative colitis, Crohn's disease, multiple sclerosis, and other medical issues.

"While older patients represent a large and growing population of medical cannabis users, few studies have addressed how it affects this particular group, which also suffers from dementia, frequent falls, mobility problems, and hearing and visual impairments," says Prof. Victor Novack, M.D., a professor of medicine in the BGU Faculty of Health Sciences (FOHS), and head of the Soroka Cannabis Clinical Research Institute. Novack is also the BGU Gussie Krupp Chair in Internal Medicine.

"After monitoring patients 65 and older for six months, we found medical cannabis treatment significantly relieves pain and improves quality of life for seniors with minimal side effects reported."

This older population represents a growing segment of medical cannabis users, ranging from approximately seven percent to more than 33 percent, depending on the country. Recent U.S. polls indicate Americans over 65 represent 14 percent of the total population and use more than 30 percent of all prescription drugs, including highly addictive painkillers.

BGU researchers surveyed 2,736 patients 65 years and older who received medical cannabis through "Tikun Olam," the largest Israeli medical cannabis supplier. More than 60 percent were prescribed medical cannabis due to the pain, particularly pain associated with cancer. After six months of treatment, more than 93 percent of 901 respondents reported their pain dropped from a median of eight to four on a 10-point scale. Close to 60 percent of patients who originally reported "bad" or "very bad" quality of life upgraded to "good" or "very good" after six months. More than 70 percent of patients surveyed reported moderate to significant improvement in their condition.

The most commonly reported adverse effects were dizziness (9.7 percent) and dry mouth (7.1 percent). After six months, more than 18 percent of patients surveyed had stopped using opioid analgesics or had reduced their dosage.

All patients received a prescription after consulting with a doctor who prescribed treatment. More than 33 percent of patients used cannabis-infused oil; approximately 24 percent inhaled therapy by smoking, and approximately six percent used vaporization.

While the researchers state their findings to date indicate cannabis may decrease dependence on prescription medicines, including opioids, more evidence-based data from this special, aging population is imperative.

The researchers in the study also include, Ran Abuhasira, a BGU Ph.D. candidate working in the Soroka Clinical Research Center, Lihi Bar-Lev Schleider of "Tikun Olam," and Prof. Raphael Mechoulam of Hebrew University. Prof. Novak is an advisor to the dean for Clinical Research in the FOHS at BGU. He is also the head of the Clinical Research Center and Research Authority at Soroka.

Attribution/Source(s):

This quality-reviewed article relating to our Medical Marijuana and Cannabis section was selected for publishing by the editors of Disabled World due to its likely interest to our disability community readers. Though the content may have been edited for style, clarity, or length, the article "Medical Cannabis Significantly Safer than Opioids for Seniors with Chronic Pain" was originally written by American Associates, Ben-Gurion University of the Negev, and published by Disabled-World.com on 2018-02-13. Should you require further information or clarification, American Associates, Ben-Gurion University of the Negev can be contacted at aabgu.org. Disabled World makes no warranties or representations in connection therewith.

Share This Information To:
𝕏.com Facebook Reddit

Discover Related Topics:

advertisement


Disabled World is an independent disability community founded in 2004 to provide disability news and information to people with disabilities, seniors, their family and/or carers. See our homepage for informative reviews, exclusive stories and how-tos. You can connect with us on social media such as X.com and our Facebook page.

Permalink: <a href="https://www.disabled-world.com/medical/pharmaceutical/marijuana/opioids.php">Medical Cannabis Significantly Safer than Opioids for Seniors with Chronic Pain</a>

Cite This Page (APA): American Associates, Ben-Gurion University of the Negev. (2018, February 13). Medical Cannabis Significantly Safer than Opioids for Seniors with Chronic Pain. Disabled World. Retrieved September 21, 2023 from www.disabled-world.com/medical/pharmaceutical/marijuana/opioids.php

Disabled World provides general information only. The materials presented are never meant to substitute for qualified professional medical care, nor should they be construed as such. Funding is derived from advertisements or referral programs. Any 3rd party offering or advertising does not constitute an endorsement.